Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19

NCT05172180 · clinicaltrials.gov ↗

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Reamberin
DRUG: Ringer's solution

Sponsor

POLYSAN Scientific & Technological Pharmaceutical Company